INS and Autoimmunity: Given the role of insulin as a major autoantigen in type 1 diabetes, the findings from these latter studies are also consistent with altered/reduced presentation of insulin antigens, leading to slower autoimmunity progression and lower type 1 diabetes penetrance in NOD mice.